Duquesne Family Office »

Beam Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.3M 154k 34.32

More positions owned by Duquesne Family Office

Natera (NTRA)
Insmed Com Par $.01 (INSM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ishares Msci Brazil Etf (EWZ)
Amazon (AMZN)
Stmicroelectronics N V Ny Registry (STM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ypf Sociedad Anonima Spon Adr Cl D (YPF)
Cdw (CDW)
Bbb Foods Cl A Com (TBBB)
Alphabet Cap Stk Cl A (GOOGL)
Seagate Technology Hldngs Pl Ord Shs (STX)
Fox Corp Cl A Com (FOXA)
Hldgs (UAL)
Sea Sponsord Ads (SE)

View all positions for Duquesne Family Office

Top funds holding Beam Therapeutics

FMR
Farallon Capital Management
ARK Investment Management
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Arch Venture Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
T. Rowe Price Associates
Geode Capital Management
Dimensional Fund Advisors
Contrarius Group Holdings

View all funds holding Beam Therapeutics